Understand decreased urine output (oliguria) and anuria. Learn about diagnosis, causes, and treatment. Find information on clinical documentation, medical coding, ICD-10 codes, and healthcare best practices related to oliguria and anuria. This resource offers guidance for physicians, nurses, and other healthcare professionals dealing with decreased urine output.
Also known as
Anuria and oliguria
Absent or markedly decreased urine production.
Diseases of the genitourinary system
Includes various kidney diseases that can cause decreased urine output.
Other specified general symptoms and signs
Can be used for decreased urine output not otherwise specified.
Hypotension, unspecified
Low blood pressure, a potential cause of reduced urine output.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is urine output < 500 ml/24h (Oliguria)?
When to use each related code
| Description |
|---|
| Low urine output |
| No urine output |
| Increased urine output |
Coding for 'Decreased Urine Output' lacks specificity. CDI should clarify if it's oliguria, anuria, or another cause, impacting reimbursement.
Failing to code the underlying etiology of decreased urine output (e.g., dehydration, AKI) leads to underreporting severity and inaccurate risk adjustment.
Insufficient documentation of the severity and duration of decreased urine output can impact severity level assignment and potential medical necessity reviews.
Q: What are the key differential diagnoses to consider in a patient presenting with decreased urine output (oliguria) in the ICU?
A: Decreased urine output (oliguria), defined as less than 0.5 mL/kg/hour in adults, can be caused by a variety of conditions in the ICU setting. Key differential diagnoses to consider include prerenal causes like hypovolemia, heart failure, and sepsis leading to reduced renal perfusion; renal (intrinsic) causes such as acute tubular necrosis (ATN), acute interstitial nephritis, and glomerulonephritis; and postrenal causes like urinary tract obstruction due to stones, blood clots, or tumors. Differentiating between these requires a thorough clinical assessment including fluid status evaluation, medication review, and imaging studies. Consider implementing a systematic approach incorporating urine microscopy, serum creatinine trends, and fractional excretion of sodium (FeNa) to accurately pinpoint the etiology. Explore how dynamic renal ultrasound can provide further insights into renal perfusion and potential obstruction.
Q: How can I quickly distinguish between prerenal oliguria and acute tubular necrosis (ATN) in a critically ill patient?
A: Distinguishing prerenal oliguria from ATN is crucial for effective management in critically ill patients. While both present with decreased urine output, prerenal oliguria results from decreased renal perfusion, while ATN involves intrinsic damage to the renal tubules. Clinically, a careful fluid challenge can help distinguish the two: improvement in urine output suggests prerenal azotemia. Laboratory tests can further aid in differentiation: patients with prerenal oliguria often have a low FeNa (less than 1%), a high urine osmolality, and a BUN/creatinine ratio greater than 20:1, indicating the kidneys are still effectively concentrating urine. Conversely, patients with ATN typically exhibit a higher FeNa (greater than 2%), a lower urine osmolality, and a BUN/creatinine ratio closer to 10:1. Learn more about the role of biomarkers like NGAL and KIM-1 in early diagnosis of ATN.
Patient presents with decreased urine output, clinically identified as oliguria, concerning for potential acute kidney injury (AKI) or chronic kidney disease (CKD). Assessment reveals urine volume less than 400 mL per 24 hours, prompting further investigation into underlying etiology. Patient denies dysuria, hematuria, or frequency. Current medications include lisinopril and atorvastatin. Physical exam demonstrates stable vital signs with no edema. Differential diagnosis includes dehydration, urinary tract obstruction, prerenal azotemia, and nephrotoxic drug effects. Laboratory studies ordered include complete blood count (CBC), basic metabolic panel (BMP), urinalysis (UA), and blood urea nitrogen (BUN) and creatinine levels to evaluate renal function and identify potential causes of oliguria. Plan includes intravenous fluid challenge with normal saline to assess for prerenal causes, strict intake and output monitoring (IandO), and medication review for nephrotoxicity. Patient education provided regarding signs and symptoms of worsening renal function and importance of compliance with treatment plan. Follow-up scheduled to reassess urine output and renal function. Diagnosis codes considered include R34.1 (Oliguria), N17.9 (Acute kidney failure, unspecified), and N18.9 (Chronic kidney disease, unspecified), pending laboratory results. ICD-10 and medical billing codes will be finalized upon completion of diagnostic workup.